Elanco Animal Health Inc Contracts & Agreements

Cooperation Agreement, dated as of March 29, 2024, by and among Elanco Animal Health Incorporated, Ancora Catalyst Institutional, LP and the other person and entities listed... (Filed With SEC on April 1, 2024)

Asset Purchase Agreement by and between Elanco Animal Health Incorporated as Seller and Intervet International as Buyer dated as of February 5, 2024 (Filed With SEC on February 5, 2024)

Receivables Loan Agreement among Elanco SPEAR LLC, Elanco US Inc., The Various Lenders and Lender Agents from Time to Time Party Thereto and Coperatieve Rabobank U.A., New York... (Filed With SEC on August 7, 2023)

Consulting Agreement, dated April 12, 2022, by and between Aaron Schacht and Elanco US Inc (Filed With SEC on August 8, 2022)

Incremental Assumption Agreement dated June 28, 2022 by and among Elanco Animal Health Incorporated, Elanco US Inc., the subsidiary loan parties party thereto, Bank of America,... (Filed With SEC on June 29, 2022)

Elanco Animal Health Incorporated Amended and Restated Employee Stock Purchase Plan (Filed With SEC on May 19, 2022)

Incremental Assumption Agreement dated April 19, 2022 by and among Elanco Animal Health Incorporated, Elanco US Inc., the subsidiary loan parties party thereto, Farm Credit... (Filed With SEC on April 20, 2022)

Services Agreement, dated as of January 1, 2022, by and between MBRD Service Company and Elanco US Inc (Filed With SEC on February 28, 2022)

Incremental Assumption Agreement dated August 12, 2021 by and among Elanco Animal Health Incorporated, Elanco US Inc., the subsidiary loan parties party thereto, Farm Credit... (Filed With SEC on August 12, 2021)

First Amendment to Agreement and Plan of Merger, dated as of June 30, 2021, by and among Elanco Animal Health Incorporated, Knight Merger Sub, Inc. and Kindred Biosciences, Inc (Filed With SEC on July 1, 2021)

Agreement and Plan of Merger, dated as of June 15, 2021, by and among Elanco Animal Health Incorporated, Knight Merger Sub, Inc. and Kindred Biosciences, Inc (Filed With SEC on June 16, 2021)

Elanco Animal Health Incorporated Amended and Restated 2018 Elanco Stock Plan (including related form agreements) (Filed With SEC on May 21, 2021)

Form of Elanco Animal Health Incorporated Restricted Stock Unit Award Agreement for executives with respect to annual awards (Filed With SEC on May 7, 2021)

Form of Elanco Animal Health Incorporated Performance-Based Restricted Stock Unit Award Agreement for executives with respect to annual awards (Filed With SEC on May 7, 2021)

Elanco Animal Health Incorporated Corporate Bonus Plan (Filed With SEC on May 7, 2021)

Elanco Executive Severance Pay Plan and Summary (Filed With SEC on March 1, 2021)

Underwriting Agreement, dated November 30, 2020, by and among Elanco Animal Health Incorporated, Bayer World Investments B.V., BofA Securities, Inc., Goldman Sachs & Co. LLC and... (Filed With SEC on December 3, 2020)

Amendment No. 4 to Share and Asset Purchase Agreement, dated as of July 30, 2020, between Bayer Aktiengesellschaft and Elanco Animal Health Incorporated (Filed With SEC on August 3, 2020)

Amendment No. 3 to Share and Asset Purchase Agreement, dated as of June 15, 2020, between Bayer Aktiengesellschaft and Elanco Animal Health Incorporated (Filed With SEC on June 18, 2020)

Form of Elanco Animal Health Incorporated Restricted Stock Unit Award Agreement for executives with respect to annual awards (Filed With SEC on May 7, 2020)

Form of Elanco Animal Health Incorporated Performance-Based Award Agreement for executives with respect to annual awards (Filed With SEC on May 7, 2020)

Elanco Animal Health Incorporated Corporate Bonus Plan (Filed With SEC on May 7, 2020)

Form of Elanco Animal Health Incorporated Sign-On Restricted Stock Unit Award Agreement for executives (Filed With SEC on May 7, 2020)

Description of Securities (Filed With SEC on February 28, 2020)

Underwriting Agreement, dated January 22, 2020, among Elanco Animal Health Incorporated and Goldman Sachs & Co. LLC, Citigroup Global Markets Inc. and J.P. Morgan Securities LLC,... (Filed With SEC on January 27, 2020)

Second Supplemental Indenture, dated as of January 27, 2020, between Elanco Animal Health Incorporated and Deutsche Bank Trust Company Americas, as trustee (Filed With SEC on January 27, 2020)

Purchase Contract Agreement, dated as of January 27, 2020, between Elanco Animal Health Incorporated and Deutsche Bank Trust Company Americas, as purchase contract agent, as... (Filed With SEC on January 27, 2020)

Amendment No. 2 to Share and Asset Purchase Agreement, dated as of January 17, 2020, between Bayer Aktiengesellschaft and Elanco Animal Health Incorporated (Filed With SEC on January 17, 2020)

First Amendment to Revolving Loan Credit Agreement, dated as of September 5, 2018, among Elanco Animal Health Incorporated, as borrower, JPMorgan Chase Bank, N.A., as... (Filed With SEC on December 20, 2019)

First Amendment to Term Loan Credit Agreement, dated as of September 5, 2018, among Elanco Animal Health Incorporated, as borrower, JPMorgan Chase Bank, N.A., as administrative... (Filed With SEC on December 20, 2019)

Amendment No. 1 to Share and Asset Purchase Agreement, dated as of October 15, 2019, between Bayer Aktiengesellschaft and Elanco Animal Health Incorporated (Filed With SEC on October 17, 2019)

Elanco Animal Health Incorporated Directors' Deferral Plan (Filed With SEC on August 13, 2019)

Elanco Animal Health Incorporated Directors' Deferral Plan (Filed With SEC on May 14, 2019)

Form of Elanco Animal Health Incorporated Restricted Stock Unit Award Agreement for non-employee directors with respect to annual awards (Filed With SEC on May 14, 2019)

Form of Elanco Animal Health Incorporated Restricted Stock Unit Award Agreement for non-employee directors with respect to one-time founder award (Filed With SEC on May 14, 2019)

Elanco Animal Health Incorporated Replacement Restricted Stock Unit Award Agreement (Filed With SEC on May 14, 2019)

Agreement and Plan of Merger, dated as of April 26, 2019, by and among Elanco Animal Health Incorporated, Elanco Athens Inc. and Aratana Therapeutics, Inc. (including the Form of... (Filed With SEC on April 26, 2019)

Form of Restricted Stock Unit Award Agreement (Filed With SEC on February 20, 2019)

Form of Replacement Performance Award Agreement for Certain Named Executive Officers (Filed With SEC on February 20, 2019)

Form of Replacement Performance Award Agreement for Jeffery N. Simmons (Filed With SEC on February 20, 2019)

Form of Replacement Restricted Stock Unit Award Agreement for Certain Named Executive Officers (Filed With SEC on February 20, 2019)

Form of Performance Award Agreement (Filed With SEC on February 19, 2019)

Form of RSU Agreement (Filed With SEC on February 19, 2019)

Employment offer letter with Mr. Todd S. Young (Filed With SEC on October 30, 2018)

Retention Bonus Agreement with Todd S. Young (Filed With SEC on October 30, 2018)

Master Separation Agreement, dated September 24, 2018, between Eli Lilly and Company and Elanco Animal Health Incorporated (Filed With SEC on September 26, 2018)

Transitional Services Agreement, dated September 24, 2018, between Eli Lilly and Company and Elanco Animal Health Incorporated (Filed With SEC on September 26, 2018)

Tax Matters Agreement, dated September 24, 2018, between Eli Lilly and Company and Elanco Animal Health Incorporated (Filed With SEC on September 26, 2018)

Employee Matters Agreement, dated September 24, 2018, between Eli Lilly and Company and Elanco Animal Health Incorporated (Filed With SEC on September 26, 2018)

Toll Manufacturing and Supply Agreement, dated September 24, 2018, between Eli Lilly Export S.A. and Elanco UK AH Limited (Filed With SEC on September 26, 2018)

Registration Rights Agreement, dated September 24, 2018, between Eli Lilly and Company and Elanco Animal Health Incorporated (Filed With SEC on September 26, 2018)

Transitional Trademark License Agreement, dated September 24, 2018, among Eli Lilly and Company, Elanco Animal Health Incorporated and Elanco US Inc (Filed With SEC on September 26, 2018)

Intellectual Property and Technology License Agreement, dated September 24, 2018, among Eli Lilly and Company, Elanco Animal Health Incorporated and Elanco US Inc (Filed With SEC on September 26, 2018)

Form of Underwriting Agreement (Filed With SEC on September 6, 2018)

FORM OF TAX MATTERS AGREEMENT BY AND BETWEEN ELI LILLY AND COMPANY AND ELANCO ANIMAL HEALTH INCORPORATED Dated as of [], 2018 (Filed With SEC on September 6, 2018)

Revolving Loan Credit Agreement, dated as of September 5, 2018, among Elanco Animal Health Incorporated, as borrower, JPMorgan Chase Bank, N.A., as administrative agent and the... (Filed With SEC on September 6, 2018)

Term Loan Credit Agreement, dated as of September 5, 2018, among Elanco Animal Health Incorporated, as borrower, JPMorgan Chase Bank, N.A., as administrative agent and the other... (Filed With SEC on September 6, 2018)

Form of Master Separation Agreement (Filed With SEC on August 2, 2018)

Form of Transitional Services Agreement (Filed With SEC on August 2, 2018)

Form of Tax Matters Agreement (Filed With SEC on August 2, 2018)

Form of Employee Matters Agreement (Filed With SEC on August 2, 2018)

Form of Toll Manufacturing and Supply Agreement (Filed With SEC on August 2, 2018)

Form of Registration Rights Agreement (Filed With SEC on August 2, 2018)

Form of Transitional Trademark License Agreement (Filed With SEC on August 2, 2018)

Form of Intellectual Property and Technology License Agreement (Filed With SEC on August 2, 2018)

The Elanco Corporate Bonus Plan (Filed With SEC on August 2, 2018)

Form of 2018 Elanco Stock Plan (Filed With SEC on August 2, 2018)

Form of Elanco Animal Health Incorporated Directors' Deferral Plan (Filed With SEC on August 2, 2018)

Director Letter Agreement between Emu Holdings Company and R. David Hoover, dated as of May 25, 2018 (Filed With SEC on August 2, 2018)

Category

Industry

Companies

Contracts

Elanco Animal Health Inc Contracts & Agreements